Evogene
Address: 13 Gad Feinstein st., , Park Rehovot, , Rehovot,About Us
Evogene Ltd. (Nasdaq/TASE: EVGN) is a pioneering company in computational chemistry, specializing in the generative design of small molecules for the pharmaceutical and agricultural industries. At the core of its technology is ChemPass AI, a proprietary generative AI engine that enables the design of novel, highly potent small molecules optimized across multiple critical parameters. This powerful platform significantly improves success rates while reducing development time and costs. Built on this powerful technological foundation, and through strategic partnerships alongside internal product development, Evogene is focused on creating breakthrough products driven by the integration of scientific innovation with real-world industry needs. We call this approach "Real-World Innovation".
Sectors
- Collaborations & Partnerships- R&D
- Collaborations & Partnerships-Services
- Contract Research & Development
- Software Services
Categories
- Software
- Software-AI
- Drug Design
- Small Molecules
News
Biomica and Lishan Biotech Ink License Agreement for Microbiome-Based Cancer Therapeutic
We’re excited to announce the expansion of our collaboration with Google Cloud marking the next phase of ChemPass AI™.
By integrating advanced AI Agents via Google Cloud’s Vertex AI, we are building on our generative AI foundation model to reach new levels of speed and precision in small-molecule discovery. This evolution is designed to accelerate the development of next-generation pharmaceutical and agricultural products.
Source: The Partnership Tree | https://www.pharmaservicesdirectory.com